That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely ...

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, ...

LLY has delivered impressive returns of 15% year-to-date (as of April 30), outperforming the S&P 500’s 5% decline during the ...

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro surged in the first quarter.

Many Medicare recipients are benefiting from changes that make prescriptions more affordable. But you can still make other ...

From a fundamental standpoint, Eli Lilly presently has a market capitalization of $789 billion. Over the trailing twelve ...

Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today ...

A local health care provider is leading a statewide organization. Dr. Edward Hosbach of Mercer Health was recently inducted ...

Healthy.io is excited to announce that it has just signed an agreement to acquire Labrador Health, a startup that has ...